Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Rossi, Oriana ^a   Van Berkel, Lisette A ^b   Chain, Florian ^c,d   Tanweer Khan, M ^e   Taverne, Nico ^a   Sokol, Harry ^c,d,f,g   Duncan, Sylvia H ^h   Flint, Harry J ^h   Harmsen, Hermie J M ^e   Langella, Philippe ^c,d   Samsom, Janneke N ^b   Wells, Jerry M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UMR1319 MICALIS   (France)

^d AGROPARISTECH   (France)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f HÔPITAL SAINT ANTOINE   (France)

^g INSERM   (France)

^h ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IL10 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; TOLL LIKE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; COLITIS; COLON; DENDRITIC CELL; FAECALIBACTERIUM PRAUSNITZII; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; SECRETION (PROCESS);

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLITIS; COLON; DENDRITIC CELLS; FAECALIBACTERIUM PRAUSNITZII; HUMANS; INTERLEUKIN-10; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; TOLL-LIKE RECEPTORS;

EID: 84953252234     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18507     Document Type: Article

References (35)

1. Whitman, W. B., Coleman, D. C. & Wiebe, W. J. Prokaryotes: The unseen majority. Proc Natl Acad Sci USA 95, 6578-6583 (1998).
2. Lopez-Siles, M. et al. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Applied and environmental microbiology 78, 420-428, doi: 10.1128/AEM.06858-11 (2012).
3. Sekirov, I., Russell, S. L., Antunes, L. C. & Finlay, B. B. Gut microbiota in health and disease. Physiological reviews 90, 859-904, doi: 10.1152/physrev.00045.2009 (2010).
4. Kiyono, H., McGhee, J. R., Wannemuehler, M. J. & Michalek, S. M. Lack of oral tolerance in C3H/HeJ mice. J Exp Med 155, 605-610 (1982).
5. Tanaka, K. & Ishikawa, H. Role of intestinal bacterial flora in oral tolerance induction. Histology and histopathology 19, 907-914 (2004).
6. Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689, doi: 10.1016/j.immuni.2009.08.020 (2009).
7. Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236, doi:10.1038/nature12331 (2013).
8. Round, J. L. & Mazmanian, S. K. Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107, 12204-12209, doi: 10.1073/pnas.0909122107 (2010).
9. Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory bowel diseases 15, 1183-1189, doi: 10.1002/ibd.20903 (2009).
10. Chassaing, B. & Darfeuille-Michaud, A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1720-1728, doi: 10.1053/j.gastro.2011.01.054 (2011).
11. Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P. & Forano, E. Microbial degradation of complex carbohydrates in the gut. Gut microbes 3, 289-306, doi: 10.4161/gmic.19897 (2012).
12. Duncan, S. H. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology 52, 2141-2146, doi: 10.1099/ijs.0.02241-0 (2002).
13. Barcenilla, A. et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Applied and environmental microbiology 66, 1654-1661 (2000).
14. Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731-16736, doi: 10.1073/pnas.0804812105 (2008).
15. Varela, E. et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Alimentary pharmacology & therapeutics 38, 151-161, doi: 10.1111/apt.12365 (2013).
16. Martin, R. et al. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflammatory bowel diseases 20, 417-430, doi: 10.1097/01.MIB.0000440815.76627.64 (2014).
17. Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S. & Flint, H. J. The microbiology of butyrate formation in the human colon. FEMS microbiology letters 217, 133-139 (2002).
18. Yin, L., Laevsky, G. & Giardina, C. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 276, 44641-44646, doi: 10.1074/jbc.M105170200 (2001).
19. Place, R. F., Noonan, E. J. & Giardina, C. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochemical pharmacology 70, 394-406, doi: 10.1016/j. bcp.2005.04.030 (2005).
20. Meijerink, M. et al. Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One 5, e10632, doi: 10.1371/journal.pone.0010632 (2010).
21. Foligne, B. et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World journal of gastroenterology : WJG 13, 236-243 (2007).
22. Wang, B., Morinobu, A., Horiuchi, M., Liu, J. & Kumagai, S. Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cellular immunology 253, 54-58, doi: 10.1016/j.cellimm.2008.04.016 (2008).
23. Erridge, C., Duncan, S. H., Bereswill, S. & Heimesaat, M. M. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One 5, e9125, doi: 10.1371/journal.pone.0009125 (2010).
24. Duncan, S. H. & Flint, H. J. Proposal of a neotype strain (A1-86) for Eubacterium rectale. Request for an opinion. Int J Syst Evol Microbiol 58, 1735-1736, doi: 10.1099/ijs.0.2008/004580-0 (2008).
25. Chevrot, R., Carlotti, A., Sopena, V., Marchand, P. & Rosenfeld, E. Megamonas rupellensis sp. nov., an anaerobe isolated from the caecum of a duck. Int J Syst Evol Microbiol 58, 2921-2924, doi: 10.1099/ijs.0.2008/001297-0 (2008).
26. Unger, W. W. et al. Early events in peripheral regulatory T cell induction via the nasal mucosa. J Immunol 171, 4592-4603 (2003).
27. Samsom, J. N. Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Critical reviews in immunology 24, 157-177 (2004).
28. Seksik, P. et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237-242 (2003).
29. Macfarlane, G. T., Blackett, K. L., Nakayama, T., Steed, H. & Macfarlane, S. The gut microbiota in inflammatory bowel disease. Current pharmaceutical design 15, 1528-1536 (2009).
30. Murai, M. et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10, 1178-1184, doi: 10.1038/ni.1791 (2009).
31. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341, doi: 10.1126/science.1198469 (2011).
32. Weintraub, A., Zahringer, U., Wollenweber, H. W., Seydel, U. & Rietschel, E. T. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem 183, 425-431 (1989).
33. Liu, Y., Michalopoulos, G. K. & Zarnegar, R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 269, 4152-4160 (1994).
34. Louis, P. et al. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. Journal of bacteriology 186, 2099-2106 (2004).
35. Duncan, S. H., Louis, P. & Flint, F. J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and environmental microbiology 70, 5810-5817, doi: 10.1128/AEM.70.10.5810-5817.2004 (2004).